Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central nervous system (CNS) stimulants. Methylphenidate is also used to treat narcolepsy. Narcolepsy is an uncontrollable desire for sleep or a sudden attack of deep sleep. It is grouped under the following drug class(es): Controlled drug substances, Psychotropic agents and Schedule II controlled substances. Its therapeutic use is listed as ADHD agents and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Phenidylate, Calocain, Daytrana and Ritaline. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 4158.
Methylphenidate
| CAS No | 113-45-1 |
|---|---|
| Molecular Formula | C14H19NO2 |
| Molecular Weight | 233.31 g/mol |
| Synonyms | methyl 2-phenyl-2-piperidin-2-ylacetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central nervous system (CNS) stimulants.
The listed CAS number is 113-45-1.
The listed molecular formula is C14H19NO2.
The listed molecular weight is 233.31 g/mol.
methyl 2-phenyl-2-piperidin-2-ylacetate.
The source lists Phenidylate, Calocain, Daytrana and Ritaline.